Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Elanco Animal Health Incorporated Cash Flow Breakdown

Cash flow breakdown shows where Elanco Animal Health Incorporated's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $560.00M came in.
  • Fiscal year ended 2025-12-31: from investing, $279.00M went out.
  • Fiscal year ended 2025-12-31: from financing, $275.00M went out.
  • Fiscal year ended 2025-12-31: change in cash, $77.00M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2025-12-31$560.00M-$279.00M-$2.67B$2.11B-$2.00M$290.00M*$77.00M
2024-12-31$541.00M$1.16B-$1.60B$350.00M-$17.00M-$225.00M*$116.00M
2023-12-31$271.00M-$169.00M-$402.00M$0.00$0.00-$6.00M$325.00M*$7.00M
2022-12-31$452.00M-$179.00M-$677.00M$425.00M-$32.00M-$265.00M*-$293.00M
2021-12-31$483.00M-$530.00M-$573.00M$500.00M-$31.00M$314.00M*$132.00M
2020-12-31-$41.00M-$4.78B-$952.00M*$4.80B$0.00*$1.22B-$16.00M-$102.00M*$161.00M
2019-12-31$224.00M-$235.00M-$121.00M$0.00$0.00*$0.00$8.00M-$192.00M*-$333.00M
2018-12-31$487.30M-$127.00M-$7.50M$2.50B$1.66B-$17.20M-$4.17B*$354.10M
2017-12-31$173.80M-$964.60M$0.00$0.00$0.00-$800.00K$848.30M*$64.60M
2016-12-31$155.90M-$182.10M$0.00$0.00$0.00$0.00-$149.60M*-$201.80M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$277.00M*-$110.00M*-$73.00M*-$1.00M*$0.00*
2026-03-31$13.00M-$60.00M-$16.00M-$34.00M-$15.00M-$117.00M
2025-12-31$108.00M*-$64.00M*-$2.11B*$2.11B*-$17.00M*
2025-09-30$219.00M*-$101.00M*-$188.00M*$21.00M*$14.00M*
2025-06-30$237.00M*-$56.00M*-$361.00M*-$1.00M*$1.00M*$205.00M*
2025-03-31-$4.00M-$58.00M-$13.00M-$13.00M-$7.00M$85.00M*$19.00M
2024-12-31$177.00M*-$90.00M*-$13.00M*$0.00*$6.00M*-$25.00M*
2024-09-30$162.00M*$1.24B*-$1.56B*-$8.00M*$230.00M*
2024-06-30$200.00M*-$33.00M*-$12.00M*-$1.00M*-$80.00M*
2024-03-31$2.00M$37.00M-$13.00M-$14.00M-$7.00M
2023-12-31$157.00M*-$35.00M*-$14.00M*$0.00*$0.00*-$125.00M*
2023-09-30$198.00M*-$36.00M*-$356.00M*$0.00*-$1.00M*$200.00M*
2023-06-30$61.00M*-$43.00M*-$13.00M*$50.00M*$2.00M*
2023-03-31-$145.00M-$55.00M-$19.00M$200.00M*-$7.00M-$27.00M
2022-12-31$13.00M*-$76.00M*-$70.00M*$0.00*$0.00*$1.00M*-$15.00M*
2022-09-30$189.00M*-$37.00M*-$79.00M*$0.00*-$75.00M*-$16.00M*$1.00M*
2022-06-30$312.00M*-$37.00M*-$439.00M*-$75.00M*-$6.00M*$424.00M*
2022-03-31-$62.00M-$29.00M-$89.00M-$100.00M*-$11.00M-$296.00M
2021-12-31$223.00M*-$74.00M*-$18.00M*$0.00*$0.00*-$14.00M*$76.00M*
2021-09-30$89.00M*-$441.00M*-$518.00M*$500.00M*$250.00M*$0.00*-$1.00M*
2021-06-30$149.00M*-$25.00M*-$17.00M*$0.00*-$50.00M*$0.00*
2021-03-31$22.00M$10.00M-$20.00M$0.00$50.00M*-$17.00M-$11.00M*$9.00M
2020-12-31-$93.00M*-$74.00M*$250.00M*$0.00*-$1.00M*-$267.00M*
2020-09-30-$112.00M*-$4.70B*$4.47B*-$1.00M*-$406.00M*
2020-06-30$160.00M*$11.00M*$0.00*-$1.00M*$8.00M*
2020-03-31$4.00M-$20.00M$79.00M$0.00-$13.00M$831.00M*$872.00M
2019-12-31$126.20M*-$74.50M*$0.00*$0.00*$6.30M*-$12.70M*
2019-09-30$39.60M*-$83.00M*$0.00*$300.00K*-$49.10M*
2019-06-30$50.10M*-$46.50M*$0.00*$1.90M*$87.80M*
2019-03-31$8.10M-$31.00M$0.00-$500.00K-$339.00M*-$376.90M
2018-12-31$139.50M*-$48.10M*$22.30M*$0.00*-$13.50M*-$371.20M*
2018-09-30$163.90M*-$21.40M*-$2.80M*$453.70M*
2018-06-30$136.90M*-$23.10M*-$500.00K*-$46.70M*
2018-03-31$47.00M-$34.40M-$400.00K-$76.10M*-$60.00M
2017-12-31$6.70M*-$35.50M*$0.00*$0.00*-$300.00K*$4.30M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05